Projects

APVV-24-0348
New methods utilizing substances of natural origin for revitalizing the intestinal microbiome and enhancing the immune response in cyprinids as well as improving aquatic environment quality in aquaculture

018UVLF-4/2025
Development of protocols for the molecular biological study of pathogenicity and virulence factors of medically important bacterial pathogens

1/0139/25
Morphological and functional changes in the gastrointestinal tract of pseudo germ-free animal model with transplant of faecal microbiota from children with autism spectrum disorders.

APVV-23-0594
Monitoring the effect of machine perfusion combined with antibiotics on kidney graft from septic donor

APVV-23-0488
Antagonistic effect of bioactive substances on clinically significant antibiotic-resistant and biofilm forming coagulase negative staphylococci

APVV-23-0031
Transplantation of faecal microbiota and its potential application in non-specific inflammatory bowel diseases in human and veterinary medicine.

20-0114
Sex-specific microbiome and gene interactions in the pathogenesis of behavioral and gastrointestinal symptoms in the animal model of autism spectrum disorder.

1/0015/21
Gnotobiotic laboratory animals associated with human microbiota in the study of prevention and therapy of inflammatory bowel diseases (IBD).

1/0731/21
Substances of natural origin as a part of sustainable aquaculture

007UVLF-4/2021
Bioinformatic and molecular tools to study factors of pathogenicity and virulence of the medically important bacterial pathogens

APVV-19-234
Development of probiotic preparation based on autochthonous lactobacilli for salmonids intended to improve fish health and production of quality food

APVV-16-0176
Targeted modulation of gut microbiota and its transplantation in prevention and treatment of inflammatory bowel diseases

APVV-15-0377
Synergistic effect of secondary metabolites of plants and products of probiotic bacteria on inhibition of biofilm-producing pathogens.